Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,858,794
  • Shares Outstanding, K 99,023
  • Annual Sales, $ 75,590 K
  • Annual Income, $ -176,060 K
  • 60-Month Beta 2.11
  • Price/Sales 46.59
  • Price/Cash Flow N/A
  • Price/Book 10.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.58
  • Number of Estimates 5
  • High Estimate -0.48
  • Low Estimate -0.81
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -728.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.50 +56.05%
on 01/03/20
31.90 -9.50%
on 01/15/20
+9.65 (+50.21%)
since 12/20/19
3-Month
14.14 +104.17%
on 10/22/19
31.90 -9.50%
on 01/15/20
+14.50 (+100.90%)
since 10/21/19
52-Week
9.51 +203.58%
on 07/22/19
31.90 -9.50%
on 01/15/20
+16.71 (+137.42%)
since 01/18/19

Most Recent Stories

More News
Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe

Novartis' (NVS) MS drug, Mayzent, obtains approval in Europe for the treatment of adult patients with secondary progressive multiple sclerosis.

NVS : 95.19 (-0.77%)
BIIB : 287.19 (+0.59%)
MNTA : 28.87 (-5.65%)
TEVA : 10.02 (-1.76%)
Momenta (MNTA) Provides Pipeline Updates, Stock Rallies

Shares of Momenta (MNTA) rise 23.7% on pipeline updates.

ALXN : 113.01 (-0.23%)
MNTA : 28.87 (-5.65%)
CLSN : 1.69 (+2.68%)
ASLN : 2.59 (-1.52%)
SmarTrend Watching for Potential Pullback in Shares of Momenta Pharmace After 7.59% Gain

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $20.42 to a high of $22.11. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high...

MNTA : 28.87 (-5.65%)
Momenta Provides Year-End 2019 Update and 2020 Outlook

-- Interim Phase 1 / 2 data of M254 in ITP supports expansion of lower dose cohorts; additional data expected Q2; plan to initiate Phase 2 study in CIDP -

MNTA : 28.87 (-5.65%)
Momenta Pharmace Up 29.7% Since SmarTrend Uptrend Call (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on October 28th, 2019 at $15.03. In approximately 2 months, Momenta Pharmace has returned 29.67% as of today's recent price of $19.49....

MNTA : 28.87 (-5.65%)
Momenta Pharmaceuticals Announces CFO Transition

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) ("Momenta" or the "Company"), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases,...

MNTA : 28.87 (-5.65%)
Momenta Pharmace Shares Up 30.9% Since SmarTrend's Buy Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on October 28th, 2019 at $15.03. In approximately 2 months, Momenta Pharmace has returned 30.87% as of today's recent price of $19.67....

MNTA : 28.87 (-5.65%)
Momenta Pharmaceuticals to Webcast Presentation at the 38th Annual J.P. Morgan Healthcare Conference

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that Craig Wheeler, President and CEO, will present at the 38th Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for...

JPM : 136.84 (-0.98%)
MNTA : 28.87 (-5.65%)
Momenta Pharmace Rises 1.46% on Heavy Volume: Watch For Potential Pullback

Momenta Pharmace (NASDAQ:MNTA) traded in a range yesterday that spanned from a low of $19.18 to a high of $19.61. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high...

MNTA : 28.87 (-5.65%)
Momenta Pharmace Has Returned 20.0% Since SmarTrend Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on October 28th, 2019 at $15.03. In approximately 2 months, Momenta Pharmace has returned 20.03% as of today's recent price of $18.04....

MNTA : 28.87 (-5.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MNTA with:

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 30.82
1st Resistance Point 29.85
Last Price 28.87
1st Support Level 28.30
2nd Support Level 27.72

See More

52-Week High 31.90
Last Price 28.87
Fibonacci 61.8% 23.35
Fibonacci 50% 20.70
Fibonacci 38.2% 18.06
52-Week Low 9.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar